Normas Clínicas para Intervenção na Doença Pulmonar Obstrutiva Crónica da Sociedade Portuguesa de Pneumologia

Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (Definitions, Epidemiology, Pathophysioly, Diagnosis, and Staging).

Am J Respir Crit Care Med, 152 (1995), pp. S78-S83

[2.]

American Thoracic Society.

Chronic bronchitis, asthma and pulmonary enphysema (A statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases).

Am Rev Respir Dis, 85 (1962), pp. 762-768

[3.]

ERS.

Optimal assessment and management of chronic obstructive pulmonary disease (COPD).

Eur Respir J, 8 (1995), pp. 1398-1420

Medline

[4.]

M. Feileib, G.H.M. Rosenber, J.G. Collins, J.E. Delozier, R. Pokrs, F.M. Chevarley.

Trends in COPD morbidity and mortality in the United States.

Am Rev Respir Dis, 140 (1989), pp. S18

[5.]

M. Higgings.

Epidemiology of obstructive pulmonary disease, WB Saunders Company, (1995), pp. 10-17

[6.]

I. Melo.

Assistência respiratória domiciliária em Portugal. Grupo “Ventiloterapia Domiciliária” da Comissão de Trabalho de Reabilitação Respiratória.

Rev Port Pneumol, (1997),

[7.]

MORT ALIDADE POR BRONQUITE CRÓNICA, BRONQUTTE NÃO ESPECIFICADA, ENFTSEMA E ASMA. Códigos A93 e 323; ICD 8, 9 e 10. Annuaire de Statistics Samtaires Mondiales de 1984 a 1995; WHO.

[8.]

T.M. Rubio, I.A. Mediavilla, C.E. Bueno, J.M. Prat, L.S. Agudo.

Enfermedad pulmonar obstructiva cronica. In: Normativa sobre diagnóstico y trataemento de la enfermedad pulmonar obstructiva crónica, pp. 5-7

[9.]

G.L. Snider, J. Kleinenm, W.M. Thurlbeck, Z.H. Bengar.

The definition of enphysema (Report of a National Heart, Lung and Blood Institute, Division of Lung Diseases Work-shop).

Am Rev Respir Dis, 132 (1985), pp. 182-185

http://dx.doi.org/10.1164/arrd.1985.132.1.182 | Medline

[1.]

American Thoracic Society Statement.

Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease.

Am J Respir Crit Care, 152 (1995), pp. S77-S120

[2.]

Austrian Society for Lung Diseases and Tuberculosis.

Guidelines for Chronic Obstructive Pulmonary Disease.

Reprint from “Osterreichische Arztezeitung”, 49 (1994), pp. I-VIII

[3.]

B. Burrows, R.J. Knudson, A.E. Camilli, S.K. Lyle, M.D. Lebowitz.

The “horse-racing effect “ and predicting decline in forced expiratory volume in one second from screening spirometry.

Am Rev Respir Dis, 135 (1987), pp. 788-793

Medline

[4.]

Canadian Thoracic Society Workshop Group.

Guidelines for the assessment and management of Chronic Obstructive Pulmonary Disease.

Can Med Assoc J, 147 (1992), pp. 420-428

[5.]

M. Cosio, H. Ghezzo, J.C. Hogg, et al.

The retations between structural changes in small airways and pulmonary function tests.

N England J Med, 298 (1977), pp. 1277-1281

[6.]

ERS-Consensus Statement.

Optimal assessment and management of chronic obstructive pulmonary disease (COPD).

Eur Respir J, 8 (1995), pp. 1398-1420

Medline

[7.]

C.M. Fletcher, R. Peto, C.M. Tinker, et al.

The natural history of chronic bronchitis and emphysema, Oxford University Press, (1976), pp. 70-85

[8.]

D. Lamb.

Chronic Obstructive Pulmonary Disease: Pathology.

Respiratory Medicine, pp. 497-507

[9.]

Panel Discussion on ATS and ERS Guidelines.

Chronic Obstructive Pulmonary Disease- Current Concepts and Future Prospects, pp. 12-14

[10.]

T.L. Petty, G.W. Silvers, R.E. Stanford.

Radial traction and small airways disease 10 excised human lungs.

Am Rev Respir Dis, 133 (1986), pp. 132-135

http://dx.doi.org/10.1164/arrd.1986.133.1.132 | Medline

[11.]

N.B. Pride.

Obstructive Pulmonary Disease: Epidemaology, aetiology and natural history.

Respiratory Medicine, pp. 475-485

[12.]

R. Tramarin, A. Torbicki, B. Marchandise, J.P. Laaban, M. Morpurgo.

Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease: a European multicentre study.

Eur Hean J, 12 (1991), pp. 103-111

[1.]

N.R. Anthonisen.

Prognosis in chronic obstructive pulmonary disease.

Eur Respir Rev, 5 (1995), pp. 310-314

[2.]

ATS Statement.

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.

Am J Resp and Crit Care Medicine, 5 (1995), pp. 152

[3.]

B. Auffarth, D.S. Postma, J.G.R. Demonchy, T.H.W. Van Der Mark, W. Boorsma, G.W. Koéter.

Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.

Thorax, 46 (1991), pp. 372-377

Medline

[4.]

E.H. Bel, A.H. Zwinderman, M.C. Timmers, J.H. Dijkman, P.J. Sterk.

The protective effect of beta 2 agonist against excessiva airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.

Thorax, 46 (1991), pp. 9-14

Medline

[5.]

R.B. Berry, M.M. Desa, J.P. Branum, R.W. Light.

Effect of theophyll'me on sleep and sleep disordered breathing in patients with chronic obstructive pulmonary disease.

Am Rev Resp Dis, 143 (1991), pp. 245-250

http://dx.doi.org/10.1164/ajrccm/143.2.245 | Medline

[6.]

Combivent Inhalation Aerosol Study Group.

In chronic obstructive pulmonary disease, a combination of ipatropium and albuterol is more effective than either agent alone.

Chest, 195 (1994), pp. 1411-1419

[7.]

ERS Statement.

Optimal assessment and management of chronic obstructive pulmonary disease.

Eur Respir J, 8 (1995), pp. 1398-1420

Medline

[8.]

N.J. Gross, Z. Bankwala.

Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease.

Am Rev Respir Dis, 136 (1987), pp. 1091-1094

http://dx.doi.org/10.1164/ajrccm/136.5.1091 | Medline

[9.]

G.W. Guyatt, M. Townsend, S.O. Pugsley, J.L. Keller, H.D. Short, O.W. Taylor, N.T. Newhouse.

Bronchodilators chronic air-flow limitation.

Am Rev Respir Dis, 135 (1987), pp. 1069-1074

http://dx.doi.org/10.1164/arrd.1987.135.5.1069 | Medline

[10.]

J.P. Hay, P. Stone, J. Carter, S. Church, A. EyreBrook, M.G. Pearson, M. Woodcock, P.M.A. Calverley.

Bronchodilator reversibility, exercise performance and breeathlessness in stable chronic obstructive disease.

Eur Resp J, 5 (1992), pp. 659-664

[11.]

J.W. Jenne.

What role for theophylline?.

Thorax, 49 (1994), pp. 97-100

Medline

[12.]

J.P. Karpel, J. Pesin, J. Greenberg, E. Gentry.

A comparison of the effects of ipatropium bromide and meta-praterenol sulfate in acute exacerbations of COPD.

Chest, 98 (1990), pp. 835-839

Medline

[13.]

J.P. Karpel.

Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.

Chest, 99 (1991), pp. 871-876

Medline

[14.]

J.P. Karpel, A. Kotch, M. Zinny, J. Pesin, J.W. Jieyne.

A comparison of inhaled ipatropium, oral theophylline plus inhaled β-agonist and combination of all three in patients with COPD.

Chest, 105 (1994), pp. 1089-1094

Medline

[15.]

P. Lange.

Corticosteroids in obstructive lung disease.

Eur Respir Rev, 5 (1995), pp. 333-338

[16.]

S.E. McKay, C.A. Howie, A.H. Thomson, B. Whiting, G.J. Addis.

Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.

Thorax, 48 (1993), pp. 227-232

Medline

[17.]

D.S. Postma, E.J. Steenhuls, L.T. Van der Weele, U.L. Sluiter.

Severe chronic aiftlow obstruction: can corticosteroids slow down progression?.

Eur J Respir Dis, 67 (1985), pp. 56-64

Medline

[18.]

D.S. Postma, J. Peters, E.J. Steenhuis, H.J. Sluiter.

Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?.

Eur Respir J, 1 (1988), pp. 22-26

Medline

[19.]

N. Svedimyr.

Adrenergic beta agonists and corticosteroids in obstructive lung disease.

Eur Respir Rev, 5 (1995), pp. 339-346

[20.]

A. Watson, T.K. Lim, H. Joyce, N.H. Pride.

Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction.

Chest, 101 (1992), pp. 350-355

Medline

[21.]

J.B. Wempe, D.S. Postma, N. Breederveld, T. Ekor, T.H. Van Der Mark, G.H. Koeter.

Effects of corticosteroids on branchodilator action in chronic obstructive lung disease.

Thorax, 47 (1992), pp. 616-621

Medline

[1.]

American Thoracic Society.

Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease.

Am J Respir Crit Care Med, 152 (1995), pp. S97-S106

[2.]

O.C. Brantigan, M.B. Kress, E.A. Mueller.

The surgical approach to pulmonary emphysema.

Dis Chest, 39 (1961), pp. 485-501

[3.]

ERS - Consensus Statement.

Optimal assessment and management of chronic obstructive pulmonary disease (COPD).

EurRespir J, 8 (1995), pp. 1409-1413

[4.]

SEPAR.

Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica, Ediciones Doyma, (1992),

[5.]

Canadian Thoracic Society Workshop Group.

Guidelines for the assessment and management of chronic obstructive pulmonary disease.

Can Med Assoc J., 147 (1992), pp. 420-428

[6.]

R.B. Celi.

Current Thoughts Regarding Treatment of Chronic Obstructive Pulmonary Disease: Obstructive Lung Diseases Part I.

Med Clin North Am, 80 (1996), pp. 589-609

Medline

[7.]

J.D. Cooper, E.P. Trulock, A.N. Triantafilou, G.A. Patterson, M.S. Pohl, P.A. Deloney, R.S. Sundaresan, C.L. Roper.

Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease.

J Thorac Cardiovasc Surg., 109 (1995), pp. 106-119

http://dx.doi.org/10.1016/S0022-5223(95)70426-4 | Medline

[8.]

J.D. Cooper, G.A. Patterson.

Lung-volume reduction surgery for severe enphysema Chest.

Surg Clin North Am., 5 (1995), pp. 815-831

[9.]

G.T. Fergusson, R.M. Cherniack.

Management of Chronic Obstructive Pulmonary Disease.

N Engl J Med., 14 (1993), pp. 1017-1022

[10.]

J.P. Lynch, E.P. Trulock.

Lung Transplantation in Chrome Airflow Limitation.

Obstructive Lung Diseases Part L Med Clin North Am, 80 (1996), pp. 657-670

[11.]

R.M. Rogers, F.C. Scriuba, R.J. Keenan.

Lung reduction surgery in chronic obstructive lung disease.

Obstructive Lung Diseases Part I. Med Clin North Am, 80 (1996), pp. 623-644

[12.]

T.K. Rogers, P. Howard.

COPD-Clinical features and management.

Respiratory Medicine,

[13.]

I. Ziment.

Pharmacologic therapy of obstructive airway disease.

Clin Chest Med., 11 (1990), pp. 461-486

Medline

[1.]

P.T.P. Bye, A.S. Esau, R.D. Levy, et al.

Ventilatory muscle function during exercise in air and oxygen in patients with chrome airflow limitation.

Am Rev Resp Dis, 132 (1982), pp. 236

http://dx.doi.org/10.1164/arrd.1985.132.2.236 | Medline

[2.]

Comissão de Trabalho de Reabilitação Funcional Respiratória da SPP.

Normas para a prescrição e controle da oxigénioterapia e ventiloterapia domiciliarias.

Arq Soc Pon Pat Resp, 2 (1991), pp. 101-111

[3.]

H.D. Krop, et al.

Neuropsycological effects of continuos oxygentherapy 10 chronic obstructive pulmonary disease.

Chest, 3 (1973), pp. 317

[4.]

R.K. Heaton, I. Grant, A.J. Mcseeny, K.M. Adazns, T.L. Petiy.

Psycologic aspects of continues and nocturnal oxygen terapy in hypoxemic chronic obstructive pulmonary disease.

Arch Intern Med, 141 (1983), pp. 1941

[5.]

P. Leger, et al.

Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chrome respiratory insufficiency.

Chest, 105 (1994), pp. 100-105

Medline

[6.]

B.E. Levine, et al.

The role of long term continuos oxygen administration in patients with chronic airway obstruction with hypoxemia.

Ann Intern Med, 4 (1967), pp. 639

[7.]

Medical Research Council Working Party.

Long term domiciliary oxygen therapy in chronic hypoxemic cor pulmonale complicating chrome bronchitis and emphysema.

Lancet, 1 (1981), pp. 691

Medline

[8.]

J.F. Muir.

Intermitent positive pressure ventilation (IPPV) 10 patients with chronic obstructive pulmonary disease (COPD).

Eur Respir Rev, 2 (1992), pp. 463-469

[9.]

Nocturnal Oxygen Therapy Trial Group.

Continuous or noctural oxygen therapy in chronic hypoxem1c obstructive lung disease.

Ann Intern Med, 93 (1980), pp. 391-398

Medline

[10.]

T.L. Petty.

Prescribing home oxygen for chronic obstrucuve pulmonary disease, Theme-Stratton, (1982),

[11.]

D. Robert, M. Gerard, P. Leger, et al.

Domiciliary ventilation by tracheostomy for chronic respiratory failure.

Rev Fr Mal Resp, 11 (1983), pp. 923-936

[12.]

A.K. Simonds, M.W. Elliott.

Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders.

Thorax, 50 (1995), pp. 604-609

Medline

[13.]

R.M. Timms, F.U. Khaja, G.W. Williams, The Nocturnal Oxygentherapy Trial Group.

Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease.

Ann Intern Med, 102 (1985), pp. 29-36

Medline

[14.]

E. Weitzenblum.

Long Term Oxygen can reverse the progression of pulmonary hypertenslon in chronic obstructive pulmonary disease.

Am Rey Resp Dis, 131 (1985), pp. 493-498

[15.]

A.A. Woodcock, E.R. Gross.

Oxygen relieves breathlessness in pink-puffers.

Lancet, 1 (1981), pp. 907

Medline

[1.]

N. Ambrosino, M. Vitacca, C. Rampulla.

Standards for rehabiltative strategies in respiratory diseases Monaldi.

Arch Chest Dis, 50 (1995), pp. 293-318

[2.]

American Thoracic Society.

Pulmonary reabiliation official American Thoracic Position Statement.

Am Rev RespirDis, 124 (1981), pp. 663-666

[3.]

H.R. Anthonisen.

Effects of smoking intervention and the use of an inhaled Anticholinergic Bronchodilator on the rate of decline of FEV 1- The Lung Health Study.

JAMA, 27 (1994), pp. 19

[4.]

ATS.

Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease.

Am J Respir Crit Care Med, 152 (1995), pp. S93-S96

[5.]

BUMS.

Outpatient pulmonary rehabilation.

Post Grad Med, (1989), pp. 129-137

[6.]

R. Casaburi, T.L. Petty.

Principles and Practice of Pulmonary Rehabiliation,

[7.]

R.M. Chemiak.

Management of Chronic Respiratory Disease National Jewish Center for Immunology and Respiratory Medecine, (1987),

[8.]

Clinics in Chest Medicine.

Smoking Cessation, 12 (1991), pp. 659-835

[9.]

Comissão de Trabalho de Reabilitação Respiratória.

Proposta de Standardização da avaliação da Deficiência, da Incapacidade e do Handicap no doente respiratório crónico.

Arq SPPR, 11 (1994), pp. 317-352

[10.]

J. Conde.

Programa Europa contra o cancro e tabagismo Conselho Prevenção do Tabagtsmo, (1994),

[11.]

Guidelines for Pulmonary Rehabilation Programs,

[12.]

Cristina Bárbara, Camila Canteiro.

O que deveser avaliado num programa de Reabilitação Respiratória.

Arq SPPR, 11 (1994), pp. 181-189

[13.]

B. Doll, R. Peto, et al.

Mortality relation to smoking.

40 years observations on British male doctors, 309 (1994), pp. 901-911

[14.]

ERS.

Consensus Statement Optimal assessment and management of chronic obstructive pulmonary disease (COPD).

Eur Respir J, 8 (1995), pp. 1407-1408

[15.]

E. Fisher.

Smoking and smoking cessation - state of art.

Am Rev Resp Dis, 142 (1990), pp. 702-720

http://dx.doi.org/10.1164/ajrccm/142.3.702 | Medline

[16.]

A.P. Fishman.

NIH workshop summary pulmonary rehabiliation research.

Am J Respir Crit Care Med, 149 (1994), pp. 825-833

http://dx.doi.org/10.1164/ajrccm.149.3.8118655 | Medline

[17.]

Pulmonary Rehabiliation.

Lung Biology in Health and Disease, pp. 91

[18.]

H. Folgering, R. Deyhuijzen, N. Cox, C. Van HerWaarden.

The rationale of pulmonar rehabilitation.

Eur Repir Rev, 1 (1991), pp. 464-471

[19.]

R.S. Goldstein.

Ventilatory muscle training.

Torax, 48 (1993), pp. 1025-1033

[20.]

Help Yourself to Beter Breatiung.

American Lung Association.

(1991),

[21.]

E. Hirsch.

Relatório Programa Europa contra o cancro.

“Métodos para deixar de fumar” Conselho Prevençã do Tabagismo, (1994),

[22.]

Hodgkin JE, Connor GL, Bell CW. eds Pulmonary Rehabiliation Guidenes to success Lippincott Company - 2nd Edition.

[23.]

D.R. Hurt.

Nicotine path therapy for smoking cessation combined with physician advice and nurse follow up: one year outcome and percentage of nicotrine replacement.

JAMA, 271 (1994), pp. 545-600

[24.]

P.W. Jones.

Disease-specific measures should be used to assess quality of life,

[25.]

S. Kira, T.L. Petty.

Progress in Domiciliary Respirtory Care Current status ad perspectiva.

Excerpta Medica, ICS, 1043 (1994),

[26.]

Le traitement ambulatoire des handicapés respiratoires,

[27.]

Frontline Treatment of COPD,